No, a patient should not take both Rapaflo and Flomax together
Taking both Rapaflo (silodosin) and Flomax (tamsulosin) together is contraindicated and should be avoided. Both medications are alpha-1 adrenergic blockers used to treat benign prostatic hyperplasia (BPH), and combining them provides no additional benefit while significantly increasing the risk of adverse effects.
Why This Combination Should Be Avoided
Same Mechanism of Action
- Both drugs work through the same pharmacological pathway—blocking alpha-1 adrenergic receptors in the prostate and bladder neck
- Using two alpha-blockers simultaneously does not provide additive therapeutic benefit for urinary symptoms 1
- The FDA drug label for Rapaflo explicitly states that "RAPAFLO should not be used in combination with other alpha-blockers" 2
Increased Risk of Adverse Effects
The combination significantly amplifies side effects without improving efficacy:
Cardiovascular risks:
- Severe orthostatic hypotension (dizziness upon standing)
- Syncope (fainting)
- Both medications can cause blood pressure drops, and combining them compounds this risk 3, 2
Other adverse effects:
- Retrograde ejaculation (occurs in 28% with silodosin alone) 2
- Dizziness and headache
- Nasal congestion
- The side effect burden increases without corresponding symptom improvement
What the Guidelines Say
The 2003 AUA guidelines clearly state that alpha-blockers like alfuzosin, doxazosin, tamsulosin, and terazosin have "equal clinical effectiveness" 1. This means:
- Switching from one alpha-blocker to another is appropriate if side effects occur
- Combining two alpha-blockers is not recommended in any guideline
- If monotherapy fails, the next step is adding a different class of medication (like a 5-alpha reductase inhibitor), not another alpha-blocker 1
Appropriate Treatment Escalation
If Flomax (tamsulosin) alone is insufficient:
Option 1: Switch alpha-blockers
- Try Rapaflo (silodosin) instead of Flomax if side effects are problematic
- Different alpha-blockers have slightly different side effect profiles (e.g., tamsulosin has lower orthostatic hypotension risk but higher ejaculatory dysfunction) 1
Option 2: Add a 5-alpha reductase inhibitor
- Combine tamsulosin with finasteride or dutasteride for patients with demonstrable prostatic enlargement 1, 4
- This combination addresses both smooth muscle tone (alpha-blocker) and prostate size (5-ARI)
Option 3: Add a PDE5 inhibitor
- Tadalafil 5mg can be combined with tamsulosin for patients with both BPH and erectile dysfunction 5
- Monitor carefully for hypotension when combining these vasodilators 3
Common Pitfall to Avoid
Do not confuse "combination therapy" with "combining two drugs from the same class." When guidelines recommend combination therapy for BPH, they mean combining drugs with complementary mechanisms (alpha-blocker + 5-ARI), not doubling up on alpha-blockers 1.
Drug Interaction Concerns
Beyond the pharmacodynamic duplication, there are additional concerns:
- Both drugs are metabolized by CYP3A4 and can interact with other medications 3, 2
- The risk of drug-drug interactions increases with polypharmacy
- Older patients (the typical BPH population) are particularly vulnerable to orthostatic hypotension from alpha-blockers 6, 7, 8
If a patient is currently taking both medications, one should be discontinued immediately after consulting with their prescribing physician. The choice of which to continue should be based on individual tolerability, side effect profile, and response to therapy.